CSIMarket
 


Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
 

Beam Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Beam Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.07 in the third quarter (Sep 30 2023)

Within sector 54 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 3355, from total ranking in the second quarter 2023 at 3466.


What is Asset Turnover Ratio?
What is Beam Therapeutics Inc Market Share?


BEAM Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change -4.33 % -5.04 % -9.64 % -10.86 % 17.65 %
Y / Y Revenue Change 8.82 % 20.8 % 187.1 % -60.76 % 1970.64 %
Asset Turnover Ratio (TTM) 0.07 0.07 0.06 0.05 0.07
BEAM's Total Ranking # 3355 # 3466 # 3440 # 2106 # 2712
Seq. Asset Change -4.4 % 1.42 % -0.38 % -0.95 % -5.11 %
Seq. Revenue Change -14.53 % -16.9 % 20.82 % 26.82 % -5.12 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 55
Healthcare Sector # 533
Overall Market # 3355

Asset Turnover Ratio Statistics
High Average Low
0.58 0.26 0
(Jun 30 2020)   (Jun 30 2021)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Prothena Corporation Public Limited Company  0.19 $ 140.977  Millions$ 741.798  Millions
Nurix Therapeutics Inc   0.19 $ 68.611  Millions$ 361.433  Millions
Accelerate Diagnostics Inc   0.19 $ 9.691  Millions$ 51.305  Millions
Pulmatrix Inc   0.19 $ 6.804  Millions$ 36.294  Millions
Insmed Inc  0.19 $ 277.639  Millions$ 1,484.541  Millions
Maravai Lifesciences Holdings Inc   0.18 $ 419.517  Millions$ 2,282.423  Millions
Butterfly Network inc   0.18 $ 68.716  Millions$ 374.515  Millions
Xencor Inc  0.18 $ 145.259  Millions$ 801.557  Millions
Xenetic Biosciences Inc   0.18 $ 2.355  Millions$ 13.287  Millions
Repare Therapeutics Inc   0.18 $ 56.692  Millions$ 322.094  Millions
Fate Therapeutics Inc   0.17 $ 106.213  Millions$ 616.111  Millions
Eiger Biopharmaceuticals Inc   0.17 $ 14.666  Millions$ 86.845  Millions
Blueprint Medicines Corporation  0.17 $ 201.145  Millions$ 1,195.504  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 130.258  Millions$ 775.269  Millions
Poseida Therapeutics Inc   0.17 $ 52.459  Millions$ 312.231  Millions
Durect Corp  0.17 $ 9.194  Millions$ 55.459  Millions
Nektar Therapeutics  0.16 $ 88.260  Millions$ 552.217  Millions
Liquidia Corporation  0.15 $ 18.317  Millions$ 122.840  Millions
Intelligent Bio Solutions Inc   0.15 $ 1.742  Millions$ 11.943  Millions
Arvinas Inc   0.15 $ 167.200  Millions$ 1,146.600  Millions
Cara Therapeutics inc   0.15 $ 21.225  Millions$ 146.310  Millions
Aadi Bioscience Inc   0.14 $ 23.255  Millions$ 161.445  Millions
Werewolf Therapeutics Inc   0.14 $ 25.725  Millions$ 179.234  Millions
Aligos Therapeutics Inc   0.14 $ 16.385  Millions$ 115.103  Millions
Uniqure N v   0.14 $ 111.899  Millions$ 787.572  Millions
Zevra Therapeutics Inc   0.14 $ 16.563  Millions$ 116.656  Millions
Impel Pharmaceuticals Inc   0.14 $ 8.223  Millions$ 58.290  Millions
Inspiremd Inc   0.14 $ 5.201  Millions$ 37.058  Millions
Marinus Pharmaceuticals Inc   0.14 $ 30.961  Millions$ 222.085  Millions
Royalty Pharma Plc  0.14 $ 2,324.234  Millions$ 16,716.148  Millions

Date modified: 2023-11-10T01:40:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com